MAPT and Alzheimer disease: Interestingly, studies using animal models of AD showed that exogenous administration of EPCs improved learning, memory, and angiogenesis, attenuated Aβ deposition, reduced p-tau levels, and up-regulated the number of tight junctions, among others.